Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AIM compared with ASST: revenue, margins and what each company keeps, and the suppliers and customers both name
AIM
AIM ImmunoTech Inc.
Change
Mkt cap
Revenue
Revenue
ASST
Strive, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AIM
AIM ImmunoTech Inc.
vs
ASST
Strive, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AIM: latest quarter is a loss; flow not drawable. ASST: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AIM
1
—
Sterling Pharma Solutions
unlisted
supplier
Shared
0
No disclosed counterparties: ASST.
Only ASST
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AIM, solid
ASST, dashed
AIM
AIM ImmunoTech Inc.
Change
0.16
▲
+6.25%
· post 0.16
Mkt cap
$4.7M
Revenue
$26,000
Q2 FY26
Revenue
$88,000
FY25
ASST
Strive, Inc.
Change
21.44
▲
+4.15%
· post 21.58
Closed
Nov 6 '26
Mkt cap
$1.5B
Revenue
$3M
Q3 FY26
Revenue
$4M
FY24
vs
Compare
Closed
Nov 6 '26
AIM
AIM ImmunoTech Inc.
vs
ASST
Strive, Inc.
0.16
▲
+6.25%
post 0.16
Price
21.44
▲
+4.15%
post 21.58
$4.7M
Mkt cap
$1.5B
Q2 FY26
$26,000
Revenue
$3M
Q3 FY26
FY25
$88,000
Revenue
$4M
FY24
Change
Change
AIM
0.16
▲
+6.25%
vs
ASST
21.44
▲
+4.15%
Closed
Nov 6 '26